Status:

COMPLETED

Efficacy of Multidimensional Management of Mild Traumatic Brain Injury

Lead Sponsor:

Institut de Recherche sur la Moelle épinière et l'Encéphale

Conditions:

Mild Traumatic Brain Injury

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Unfavorable outcomes (UO) are seen in 15 to 20% of patients with mild traumatic brain injury (mTBI). Early identification of patients at risk for UO is crucial for suitable management to be initiated,...

Eligibility Criteria

Inclusion

  • \- Patients aged 18 to 65 who have suffered mTBI, have health care coverage, who understand French, who can be followed for 6 months, and who are able to understand, reply, and cooperate.

Exclusion

  • Patient intubated and/or ventilated and/or sedated upon arrival at hospital
  • Patient with injury to the medulla and with neurological signs or multiple injuries (at least 1 of which is life-threatening)
  • Brain injury incurred during a suicide attempt
  • Patient presenting psychiatric or psychological disorders that are debilitating and/or interfere with follow-up and/or evaluation
  • Psychoactive treatment ongoing at the time of injury
  • History of hospitalization in specialized a psychiatric setting and/or sick leave for psychological reasons
  • Patient with a neurological disorder
  • Patient with substance dependence
  • Subject under guardianship or wardship

Key Trial Info

Start Date :

April 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2013

Estimated Enrollment :

221 Patients enrolled

Trial Details

Trial ID

NCT03811626

Start Date

April 1 2012

End Date

June 30 2013

Last Update

January 24 2019

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Chu Bicetre

Le Kremlin-Bicêtre, France

2

Chu Montpellier

Montpellier, France

3

Chu Bichat/Beaujon

Paris, France

4

CHU St ANTOINE

Paris, France